Skip to content

DR. MALEUX - DR. WITTERS

Active
Private limited companyfounded 200917 yrs activeOostervenne 4, 3600 Genk, BelgiumKBO/BCE: BE 0810.197.646

DR. MALEUX - DR. WITTERS has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €927k and a net result of €183k. Equity is growing by ~5.5% per year across the filed fiscal years. Its solvency ranks better than 57% of 2324 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
93 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86▲+10
Solvency93▲+7
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €85k at 30 days acceptable
Liquidity ample (current ratio 4.51 against 3.32 in 2024; short-term debt: 19.4% and cash: 37.1% of total assets), and 31.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
68.4%
Return on assets
13.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-05-2026, 70 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
70 d early
2024
43 d early
2023
6 d late
2022
17 d late
2021
32 d early
2020
46 d early
2019
33 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€927k▲ 24.5%
2024 · €745k
2018: €564k 2019: €666k 2020: €625k 2021: €611k 2022: €655k 2023: €702k 2024: €745k
2018 → 2025
Total assets
€1.36M▲ 10.2%
2024 · €1.23M
2018: €959k 2019: €1.09M 2020: €1.13M 2021: €1.08M 2022: €1.05M 2023: €1.15M 2024: €1.23M
2018 → 2025
Net result
€183k▼ 2.8%
2024 · €188k
2018: €128k 2019: €145k 2020: €119k 2021: €132k 2022: €113k 2023: €176k 2024: €188k
2018 → 2025
Working capital
€923k▲ 25.1%
2024 · €738k
2018: €541k 2019: €607k 2020: €586k 2021: €569k 2022: €599k 2023: €689k 2024: €738k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€611k-€655k▲ 7.2%€702k▲ 7.3%€745k▲ 6.0%€927k▲ 24.5%
Operating result€192k-€230k▲ 19.7%€228k▼ 0.9%€252k▲ 10.9%€263k▲ 4.2%
Net result€132k-€113k▼ 14.9%€176k▲ 56.6%€188k▲ 6.5%€183k▼ 2.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €192k€192kNet result 2021: €132k€132kOperating result 2022: €230k€230kNet result 2022: €113k€113kOperating result 2023: €228k€228kNet result 2023: €176k€176kOperating result 2024: €252k€252kNet result 2024: €188k€188kOperating result 2025: €263k€263kNet result 2025: €183k€183k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 4% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.36M
Fixed assets €170k▼ 2.9%
Current assets €1.19M▲ 12.4%
Equity and liabilities €1.36M
Equity €927k▲ 24.5%
Provisions €67k=
Debt €362k▼ 13.6%
The debt ratio falls from 34.0% to 26.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€307k
2024 · €292k
Cash flow
€227k
2024 · €228k
Solvency
68.4%
2024 · 60.5%
Current ratio
4.51
2024 · 3.32
Quick ratio
4.51
2024 · 3.32
Debt / equity
0.39
2024 · 0.56
ROE
19.7%
2024 · 25.2%
ROA
13.5%
2024 · 15.3%
Interest coverage
65.53
2024 · -50.88
Debt
€362k
2024 · €418k
Debt ≤ 1 year
€263k
2024 · €317k
Debt > 1 year
€89k
2024 · €101k
Income taxes
€84k
2024 · €83k
Staff costs
€141k
2024 · €132k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.23M€1.36M
Fixed assets21/28€175k€170k
Tangible fixed assets22/27€175k€170k
Land and buildings22€141k€116k
Plant, machinery and equipment23€32k€48k
Furniture and vehicles24€2k€6k
Current assets29/58€1.06M€1.19M
Amounts receivable within one year40/41€145k€161k
Trade receivables40€145k€161k
Other amounts receivable41€0-
Current investments50/53€513k€512k
Cash at bank and in hand54/58€393k€503k
Deferred charges and accrued income490/1€4k€10k
Equity and liabilities
Total equity and liabilities10/49€1.23M€1.36M
Equity10/15€745k€927k
Contributions10/11€6k€6k=
Reserves13€738k€921k
Distributable reserves133€738k€921k
Profit (loss) carried forward14€0€0=
Provisions and deferred taxes16€67k€67k=
Provisions for liabilities and charges160/5€67k€67k=
Pensions and similar obligations160€67k€67k=
Amounts payable17/49€418k€362k
Amounts payable after more than one year17€101k€89k
Financial debts170/4€101k€89k
Amounts payable within one year42/48€317k€263k
Current portion of amounts payable after more than one year42€28k€36k
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€2k€5k
Suppliers440/4€2k€5k
Taxes, remuneration and social security45€84k€78k
Taxes450/3€62k€55k
Remuneration and social security454/9€22k€23k
Other amounts payable47/48€204k€145k
Accrued charges and deferred income492/3€0€10k
Income statement Code20242025
Non-recurring operating income76A€3k€0
Remuneration, social security and pensions62€132k€141k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40k€44k
Other operating charges640/8€4k€4k
Non-recurring operating charges66A-€26k
Gross operating margin9900€429k€478k
Operating profit (loss)9901€252k€263k
Financial income75/76B€13k€9k
Recurring financial income75€13k€9k
Financial charges65/66B€-6k€5k
Recurring financial charges65€-6k€5k
Profit (loss) for the period before taxes9903€271k€267k
Income taxes67/77€83k€84k
Profit (loss) for the period9904€188k€183k
Profit (loss) for the period to be appropriated9905€188k€183k
Appropriation of the result
Profit (loss) to be appropriated9906€188k€183k
Transfer from equity791/2€145k€0
Transfer to equity691/2€188k€183k
To other reserves6921€188k€183k
Profit to be distributed694/7€145k€0
Return on contributions (dividend)694€145k€0
Social balance
Average headcount (FTE)90872.62.3

The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
22-05
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
18-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Highest result since 2018net €188k ▲6.5%
Net result €188k, the highest in the series.
06-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 6 days late
2023
17-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 17 days late
2022
31-12
Financial Weakest financial yearnet €113k ▼14.9%
Net result drops to €113k, the lowest in the series; recovery starts the following year.
29-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
15-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
02-09
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 33 days late
2019
04-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
09-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 9 days late
2017
09-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Oostervenne 43600 Genk
Ground area
7,920 m²
Building footprint
841 m²
Volume, LiDAR
7,183 m³
2 parcels, Flanders · tallest building 15.8 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DR. MALEUX - DR. WITTERS bvba
Oude Markt 14, 3600 GenkSpecialist medical practice
since 20092.177.735.122
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71016I1367/00N000 Flanders 4,088 m² 1 · 183 m² 8.3 m · 2 fl.
71305F0668/00A002 Flanders 3,832 m² 1 · 658 m² 15.8 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 5,860 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded03-03-2009
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.